Trial intelligence / Profile preview

Etomidate preadministration for prevention of propofol injection pain during painless endoscopy

ChiCTR1900026561Phase 4Recruiting

Sponsor
Fujian Provincial Hospital South Hospital
Start
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of etomidate and propofol in propofol injection site pain (PISP) (2 arms), sponsored by Fujian Provincial Hospital South Hospital. Primary endpoint: Intravenous pain. Started Nov 2019; status: recruiting.

02

Drugs

etomidatepropofol
03

Conditions

propofol injection site pain (PISP)

Beyond the preview

Go deeper on ChiCTR1900026561.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900026561.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call